Half-Year Results: CYBG puts Brexit fears, Virgin Money acquisition aside to post net profit

The CYBG PLC Ltd (ASX: CYB) share price is on watch this morning after the company posted an A$531 million underlying profit after tax in its half-year results yesterday.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CYBG PLC Ltd (ASX: CYB) share price is on watch this morning after the company posted a A$531 million underlying profit after tax in its half-year report at market close.

What were the highlights from the half-year result?

CYBG posted a resilient underlying financial result despite statutory numbers feeling the impact of acquisition and integration costs.

CYBG's total underlying income of GBP843 million (A$1.57 billion) in the first six months was in line with both 1H19 and 2H18 figures, with net interest margin (NIM) for the UK banking group coming in at 171 bps largely due to mortgage pricing pressures.

The company's underlying profit was 5% lower on prior corresponding period due to an anticipated increase in impairments but managed to climb 2% higher on 2H 2018 numbers.

Underlying costs were 3% lower year-on-year (YoY) with underlying cost to income ratio for the group 200 bps lower at 57% for the period.

In terms of customer growth, CYBG saw customer lending growth of 2.4% in the period to GBP 72.7 billion (A$135.1 billion) with disciplined mortgage balance growth, SME growth and unsecured balances on Virgin Atlantic credit cards all driving the result.

Customer deposits rose 1.2% to GBP 61.7 billion (A$114.7 billion) with an increase in relationship savings balances as the group looks to optimise its funding and lending mixes.

In terms of capital adequacy, CYBG reported a common equity tier 1 (CET1) capital ratio of 14.5%, with a 60 bps reduction on 30 September 2018 numbers reflecting acquisition and integration costs, a small conduct provision top-up as well as dividend and additional tier 1 (AT1) distributions.

What's been happening for CYBG?

CYBG PLC is a holding company that owns several banks in the UK including Clydesdale Bank, Yorkshire Bank, Virgin Money UK and B which was established by National Australia Bank Ltd (ASX: NAB) in February 2016.

The major acquisition for CYBG during the period was the addition of Virgin Money to its portfolio for GBP 1.7 billion (A$3.2 billion).

This represents the first statutory profit posted since the October 2018 acquisition, however, it's clear that the acquisition and transition costs weighed on the headline numbers despite strong underlying results.

Motley Fool contributor Lachlan Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why AIC Mines, ASX, Karoon Energy, and Life360 shares are falling today

These shares are falling more than most on Tuesday. But why?

Read more »

green lithium battery being held by person
Broker Notes

Forget Pilbara Minerals! Expert says this ASX lithium stock could soar 112%

Strategically important.

Read more »